Tumor-secreted LOXL2 Activates Fibroblasts Through FAK Signaling
Reads0
Chats0
TLDR
In conclusion, inhibition of LOXL2 in tumors not only reduces tumor cell invasion but also attenuates the activation of host cells in the tumor microenvironment, revealing new insight into the mechanisms of fibroblast activation, a novel function of LO XL2.Abstract:
Cancer-associated fibroblasts enhance cancer progression when activated by tumor cells through mechanisms not yet fully understood. Blocking mammary tumor cell–derived lysyl oxidase-like 2 (LOXL2) significantly inhibited mammary tumor cell invasion and metastasis in transgenic and orthotopic mouse models. Here, we discovered that tumor-derived LOXL2 directly activated stromal fibroblasts in the tumor microenvironment. Genetic manipulation or antibody inhibition of LOXL2 in orthotopically grown mammary tumors reduced the expression of α-smooth muscle actin (α-SMA). Using a marker for reticular fibroblasts, it was determined that expression of α-SMA was localized to fibroblasts recruited from the host tissue. This marker also revealed that the matrix present in tumors with reduced levels of LOXL2 was more scattered compared with control tumors which exhibited matrices with dense, parallel alignments. Importantly, in vitro assays revealed that tumor-derived LOXL2 and a recombinant LOXL2 protein induced fibroblast branching on collagen matrices, as well as increased fibroblast-mediated collagen contraction and invasion of fibroblasts through extracellular matrix. Moreover, LOXL2 induced the expression of α-SMA in fibroblasts grown on collagen matrices. Mechanistically, it was determined that LOXL2 activated fibroblasts through integrin-mediated focal adhesion kinase activation. These results indicate that inhibition of LOXL2 in tumors not only reduces tumor cell invasion but also attenuates the activation of host cells in the tumor microenvironment.
Implications: These findings reveal new insight into the mechanisms of fibroblast activation, a novel function of LOXL2, and further highlight the importance of generating LOXL2-targeted therapies for the prevention of tumor progression and metastasis. Mol Cancer Res; 11(11); 1425–36. ©2013 AACR .
This article is featured in Highlights of This Issue, [p. 1293][1]
[1]: /lookup/volpage/11/1293?iss=11read more
Citations
More filters
Journal ArticleDOI
FAK in cancer: mechanistic findings and clinical applications
TL;DR: Focal adhesion kinase signalling effects on both tumour and stromal cell biology that provide rationale and support for future therapeutic opportunities are discussed.
Journal ArticleDOI
TGFβ biology in cancer progression and immunotherapy.
TL;DR: Inhibition of TGFβ signalling is currently being evaluated in multiple clinical trials as a major avenue to enhance the efficacy of cancer immunotherapies but systemic adverse effects and the therapeutic index need careful consideration.
Journal ArticleDOI
Targeting ECM Disrupts Cancer Progression.
TL;DR: The influence of several ECM proteins on these multiple steps of cancer spread is summarized and the promising (pre-)clinical data showing benefits of targeting these ECM macromolecules to prevent cancer progression are highlighted.
Journal ArticleDOI
Emerging Roles of Focal Adhesion Kinase in Cancer
TL;DR: An overview for FAK signaling in cancer cells as well as tumor microenvironment that provides new strategies for the invention of cancer development and malignancy is given.
Journal ArticleDOI
Tissue Force Programs Cell Fate and Tumor Aggression
TL;DR: Recent findings argue that mechanical stress and elevated mechanosignaling foster malignant transformation and metastasis, and strategies that could reduce tumor mechanics might comprise effective approaches to prevent the emergence of treatment-resilient metastatic cancers.
References
More filters
Journal ArticleDOI
Integrins: versatility, modulation, and signaling in cell adhesion.
Journal ArticleDOI
Fibroblasts in cancer
TL;DR: Fibroblasts are a key determinant in the malignant progression of cancer and represent an important target for cancer therapies.
Journal ArticleDOI
Myofibroblasts and mechano-regulation of connective tissue remodelling
TL;DR: It is clear that the understanding of the myofibroblast — its origins, functions and molecular regulation — will have a profound influence on the future effectiveness not only of tissue engineering but also of regenerative medicine generally.
Journal ArticleDOI
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Kandice R. Levental,Hongmei Yu,Laura Kass,Johnathon N. Lakins,Mikala Egeblad,Janine T. Erler,Sheri F. T. Fong,Katalin Csiszar,Amato J. Giaccia,Wolfgang Weninger,Mitsuo Yamauchi,David L. Gasser,Valerie M. Weaver +12 more
TL;DR: Reduction of lysyl oxidase-mediated collagen crosslinking prevented MMTV-Neu-induced fibrosis, decreased focal adhesions and PI3K activity, impeded malignancy, and lowered tumor incidence, and data show how collagenCrosslinking can modulate tissue fibrosis and stiffness to force focal adhesion, growth factor signaling and breast malignancies.
Journal ArticleDOI
Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion
Akira Orimo,Piyush Gupta,Dennis C. Sgroi,Fernando Arenzana-Seisdedos,Thierry Delaunay,Rizwan Naeem,Vincent J. Carey,Andrea L. Richardson,Robert A. Weinberg +8 more
TL;DR: Using a coimplantation tumor xenograft model, it is demonstrated that carcinoma-associated fibroblasts extracted from human breast carcinomas promote the growth of admixed breast carcinoma cells significantly more than do normal mammaries derived from the same patients.
Related Papers (5)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment.
Vivian Barry-Hamilton,Rhyannon Spangler,Derek Marshall,Scott Alan Mccauley,Hector Rodriguez,Miho Oyasu,Amanda Mikels,Maria Vaysberg,Haben Ghermazien,Carol Wai,Carlos Aurelio Garcia,Arleene C. Velayo,Brett Jorgensen,Donna Hiroko Tokuoka Biermann,Daniel Tsai,Jennifer Green,Shelly Zaffryar-Eilot,Alison Kay Holzer,Scott Ogg,Dung Thai,Gera Neufeld,Peter Van Vlasselaer,Victoria Smith +22 more